News
QIAGEN expands QIAstat-Dx syndromic testing menu and announces launch plans for new QIAstat-Dx Rise higher-throughput version
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced important enhancements in the commercialization of its QIAstat-Dx syndromic testing solution – which enables laboratories and
QIAGEN erweitert QIAstat-Dx-Menü um weitere syndromische Tests und kündigt Pläne zur Einführung der neuen Version QIAstat-Dx Rise mit höherem Durchsatz an
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) gab heute bedeutende Fortschritte bei der Kommerzialisierung seiner syndromischen Testlösung QIAstat-Dx bekannt, mit der Labore und
NuStar to Participate in the 2022 UBS Winter Infrastructure & Energy Conference
NuStar Energy L.P. (NYSE: NS) announced today that members of management will participate in virtual meetings with members of the investment community at the 2022 UBS Winter Infrastructure & Energy
AMN Healthcare Announces Preliminary Fourth Quarter 2021 Revenue; To Present at J.P. Morgan Healthcare Conference
AMN Healthcare Services (NYSE: AMN) is providing preliminary unaudited consolidated revenue results for the fourth quarter of 2021 to facilitate the Company’s participation in the 40th Annual J.P
Guidewire Announces Aspire Systems, Inc. as New Consulting Alliance Partner
Guidewire (NYSE: GWRE) announced that Aspire Systems, Inc., a global technology services firm providing digital transformation services, has joined Guidewire PartnerConnect as a Consulting alliance
Guidewire Announces Aspire Systems, Inc. as new Consulting Alliance Partner
Guidewire (NYSE: GWRE) announced that Aspire Systems, Inc., a global technology services firm providing digital transformation services, has joined Guidewire PartnerConnect as a Consulting alliance
Novocure Announces Preliminary Full Year and Fourth Quarter 2021 Net Revenues and Provides Company Update
Novocure (NASDAQ: NVCR) today reported preliminary unaudited financial results and operational updates for the quarter and full year ended December 31, 2021.* Novocure is a global oncology company
DGAP-News: GEA Group Aktiengesellschaft: Eine Kapitalmarktinformation
DGAP-News: GEA Group Aktiengesellschaft: A capital market information
DGAP-News: MorphoSys To Present At the 40th Annual J.P. Morgan Healthcare Conference
DGAP-News: MorphoSys präsentiert auf der 40. jährlichen J.P. Morgan Healthcare Conference
Semtech Supports Development of LoRa®-enabled Applications for Social and Environmental Use Cases
Semtech Corporation (Nasdaq: SMTC), a leading global supplier of high performance analog and mixed-signal semiconductors and advanced algorithms, has entered into a consulting arrangement with
Cushman & Wakefield Expands Appraisal Platform in North Carolina through Asset Acquisition
Cushman & Wakefield (NYSE: CWK) announced the firm has acquired substantially all of the assets of North by Northwest Consulting (NxNW), a valuation services firm led by Anthony Alderman and based
Roku Announces Scott Rosenberg to Step Down as SVP and GM of Platform Business
Roku, Inc. (NASDAQ: ROKU) announced today that Scott Rosenberg, Senior Vice President and General Manager of Platform Business, plans to step down sometime in the spring of 2022. Rosenberg joined
AGCO Announces 2021 Fourth Quarter Earnings Release and Conference Call
AGCO, Your Agriculture Company, (NYSE: AGCO), a worldwide manufacturer and distributor of agricultural machinery and precision ag technology, announced today its 2021 Fourth Quarter Earnings
QIAGEN stärkt das wachsende Anwendungsportfolio seiner digitalen PCR-Plattform QIAcuity mit neuen Kooperationen
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) gab heute Informationen zu zwei Neuzugängen im wachsenden Anwendungsportfolio von QIAcuity, seiner Plattform zur Durchführung
QIAGEN Strengthens Growing Portfolio of Applications for Its Digital PCR Platform QIAcuity With New Collaborations
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced new additions to the growing number of applications for QIAcuity, its ultrasensitive digital PCR (dPCR) platform that has set
DGAP-News: MorphoSys Reports Preliminary 2021 Monjuvi U.S. Sales and Provides 2022 Financial Guidance
DGAP-News: MorphoSys gibt vorläufigen Monjuvi-Umsatz für 2021 bekannt und veröffentlicht Finanzprognose für 2022
DGAP-Adhoc: MorphoSys AG gibt vorläufigen Monjuvi-Umsatz für 2021 bekannt und veröffentlicht Finanzprognose für 2022
DGAP-Adhoc: MorphoSys AG Reports Preliminary 2021 Monjuvi U.S. Sales and Provides 2022 Financial Guidance
Xencor to Present at the H.C. Wainwright Bioconnect Virtual Conference
Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases, today announced
QIAGEN Expands QuantiFERON Portfolio in the Fight Against TB
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced important expansion initiatives for its QuantiFERON franchise, building on its status as the gold standard for detection of
Royal Gold Presenting at the 25th Annual CIBC Western Institutional Investor Conference (Virtual)
Royal Gold, Inc. (NASDAQ: RGLD) (together with its subsidiaries, “Royal Gold” or the “Company,” “we” or “our”) announced today that management will present in the 25th Annual CIBC Western
QIAGEN erweitert sein QuantiFERON-Portfolio im Kampf gegen TB
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) gab heute Details zur Erweiterung seines QuantiFERON-Portfolios bekannt. Basierend auf dem Status von QuantiFERON als Goldstandard zur